Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannah W Song

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cytotherapy|December 9, 2024
Efficient manufacturing of CAR-T cells from whole blood: a scalable approach to reduce costs and enhance accessibility in cancer therapyRoshini Traynor, Isabella Vignola, Sarmila Sarkar, et al.
Cytotherapy|April 16, 2024
CAR-T cell expansion platforms yield distinct T cell differentiation statesHannah W Song, Michaela Prochazkova, Lipei Shao, et al.
Nature Communications|June 15, 2019
Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function and shuttling of drugs and antibodiesTae-Eun Park, Nur Mustafaoglu, Anna Herland, et al.
Molecular Therapy. Methods & Clinical Development|February 1, 2024
Manufacture of CD22 CAR T cells following positive versus negative selection results in distinct cytokine secretion profiles and γδ T cell outputHannah W Song, Mehdi Benzaoui, Alka Dwivedi, et al.
Journal of Translational Medicine|July 16, 2026
Development of a 3-day manufacturing method to generate CD19-CD20-CD22 trispecific CAR T-cells from whole bloodIsabella Vignola, Michaela Prochazkova, Lipei Shao, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cytotherapy|December 9, 2024
Efficient manufacturing of CAR-T cells from whole blood: a scalable approach to reduce costs and enhance accessibility in cancer therapyRoshini Traynor, Isabella Vignola, Sarmila Sarkar, et al.
Cytotherapy|April 16, 2024
CAR-T cell expansion platforms yield distinct T cell differentiation statesHannah W Song, Michaela Prochazkova, Lipei Shao, et al.
Nature Communications|June 15, 2019
Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function and shuttling of drugs and antibodiesTae-Eun Park, Nur Mustafaoglu, Anna Herland, et al.
Molecular Therapy. Methods & Clinical Development|February 1, 2024
Manufacture of CD22 CAR T cells following positive versus negative selection results in distinct cytokine secretion profiles and γδ T cell outputHannah W Song, Mehdi Benzaoui, Alka Dwivedi, et al.
Journal of Translational Medicine|July 16, 2026
Development of a 3-day manufacturing method to generate CD19-CD20-CD22 trispecific CAR T-cells from whole bloodIsabella Vignola, Michaela Prochazkova, Lipei Shao, et al.
Pageof 2